Hollis E. Krug

1.2k total citations
35 papers, 937 citations indexed

About

Hollis E. Krug is a scholar working on Rheumatology, Physiology and Pharmacology. According to data from OpenAlex, Hollis E. Krug has authored 35 papers receiving a total of 937 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Rheumatology, 8 papers in Physiology and 7 papers in Pharmacology. Recurrent topics in Hollis E. Krug's work include Rheumatoid Arthritis Research and Therapies (9 papers), Pain Mechanisms and Treatments (8 papers) and Botulinum Toxin and Related Neurological Disorders (6 papers). Hollis E. Krug is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (9 papers), Pain Mechanisms and Treatments (8 papers) and Botulinum Toxin and Related Neurological Disorders (6 papers). Hollis E. Krug collaborates with scholars based in United States, Australia and France. Hollis E. Krug's co-authors include Maren L. Mahowald, Steven R. Ytterberg, Jasvinder A. Singh, Kristen Johnson, Lovisa Hessle, Erica B. Stern, James W. Goding, Robert Terkeltaub, Shou‐Ih Hu and A. Sali and has published in prestigious journals such as CHEST Journal, Journal of Bone and Mineral Research and Annals of the Rheumatic Diseases.

In The Last Decade

Hollis E. Krug

34 papers receiving 900 citations

Peers

Hollis E. Krug
Edgar M. Colin Netherlands
A J Wysenbeek Israel
Béatrice Bouvard France
J Pourel France
Maria Elena Secchi Italy
B Zimmermann United States
A K Bhalla United Kingdom
R. W. Strachan United Kingdom
Folke D. Lindström Sweden
Daisuke Kobayashi Japan
Edgar M. Colin Netherlands
Hollis E. Krug
Citations per year, relative to Hollis E. Krug Hollis E. Krug (= 1×) peers Edgar M. Colin

Countries citing papers authored by Hollis E. Krug

Since Specialization
Citations

This map shows the geographic impact of Hollis E. Krug's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hollis E. Krug with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hollis E. Krug more than expected).

Fields of papers citing papers by Hollis E. Krug

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hollis E. Krug. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hollis E. Krug. The network helps show where Hollis E. Krug may publish in the future.

Co-authorship network of co-authors of Hollis E. Krug

This figure shows the co-authorship network connecting the top 25 collaborators of Hollis E. Krug. A scholar is included among the top collaborators of Hollis E. Krug based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hollis E. Krug. Hollis E. Krug is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Scanzello, Carla R., Karen A. Hasty, Christine B. Chung, et al.. (2024). Teaming up to overcome challenges toward translation of new therapeutics for osteoarthritis. Journal of Orthopaedic Research®. 42(12). 2659–2672. 2 indexed citations
2.
James, Lisa M., Scott M. Lewis, Adam Carpenter, et al.. (2021). Lupus Anticoagulant in Gulf War Illness and Autoimmune Disorders: A Common Pathway Toward Autoimmunity. PubMed. 5(1). 14–18. 4 indexed citations
3.
Krug, Hollis E., et al.. (2020). Programmed cell death protein 1 inhibitor-induced recalcitrant mixed small and medium vessel vasculitis. Dermatology Online Journal. 26(9). 2 indexed citations
4.
Krug, Hollis E., et al.. (2020). The Use of Botulinum Toxin for the Treatment of Chronic Joint Pain: Clinical and Experimental Evidence. Toxins. 12(5). 314–314. 13 indexed citations
5.
Krug, Hollis E., et al.. (2018). 4:12 PM Abstract No. 209 Neovascularization in knee osteoarthritis: a new mouse model using micro computed tomography to delineate pathological vascular remodeling. Journal of Vascular and Interventional Radiology. 29(4). S91–S91. 1 indexed citations
6.
7.
Mahowald, Maren L., et al.. (2016). The effect of intra-articular vanilloid receptor agonists on pain behavior measures in a murine model of acute monoarthritis. Journal of Pain Research. Volume 9. 563–570. 15 indexed citations
8.
Krug, Hollis E., et al.. (2010). Analgesic effects of intra-articular botulinum toxin Type B in a murine model of chronic degenerative knee arthritis pain. Journal of Pain Research. 3. 161–161. 23 indexed citations
9.
Mahowald, Maren L., Hollis E. Krug, Jasvinder A. Singh, & Dennis D. Dykstra. (2009). Intra-articular Botulinum Toxin Type A: A new approach to treat arthritis joint pain. Toxicon. 54(5). 658–667. 47 indexed citations
10.
Anderson, Scott A., et al.. (2009). 497 ANALGESIC EFFECTS OF INTRA-ARTICULAR BOTULINUM TOXIN TYPE B IN A MURINE MODEL OF CHRONIC DEGENERATIVE ARTHRITIS. Osteoarthritis and Cartilage. 17. S267–S268. 1 indexed citations
11.
Krug, Hollis E., et al.. (2009). Pain Behavior Measures to Quantitate Joint Pain and Response to Neurotoxin Treatment in Murine Models of Arthritis. Pain Medicine. 10(7). 1218–1228. 34 indexed citations
12.
Townes, John M., Atul Deodhar, Kirk Smith, et al.. (2008). Reactive arthritis following culture-confirmed infections with bacterial enteric pathogens in Minnesota and Oregon: a population-based study. Annals of the Rheumatic Diseases. 67(12). 1689–1696. 106 indexed citations
13.
Singh, Jasvinder A., et al.. (2007). Accuracy of the diagnoses of spondylarthritides in veterans affairs medical center databases. Arthritis Care & Research. 57(4). 648–655. 58 indexed citations
14.
Krug, Hollis E., et al.. (2000). Tolerability and efficacy of nabumetone and naproxen in the treatment of rheumatoid arthritis. Clinical Therapeutics. 22(1). 40–52. 9 indexed citations
15.
Krug, Hollis E.. (1998). Fibroblasts from Mice with Progessive Ankylosis Proliferate Excessively in Response to Transforming Growth Factor-Beta 1. Journal of Investigative Medicine. 46(4). 134–139. 7 indexed citations
16.
Stern, Erica B., et al.. (1997). Commercial wrist extensor orthoses: A descriptive study of use and preference in patients with rheumatoid arthritis. Arthritis & Rheumatism. 10(1). 27–35. 20 indexed citations
17.
Krug, Hollis E., et al.. (1997). Murine progressive ankylosis is not immunologically mediated.. PubMed. 24(1). 115–22. 18 indexed citations
18.
Krug, Hollis E., Maren L. Mahowald, Paul B. Halverson, John D. Sallis, & Herman S. Cheung. (1993). Phosphocitrate prevents disease progression in murine progressive ankylosis. Arthritis & Rheumatism. 36(11). 1603–1611. 41 indexed citations
19.
Toher, Cynthia, Hollis E. Krug, & Stephen L. Archer. (1993). Diagnosis of Pulmonary Vein Varix by Transesophageal Echocardiography. CHEST Journal. 103(6). 1901–1903. 11 indexed citations
20.
Krug, Hollis E. & Maren L. Mahowald. (1991). Transient inhibition of murine progressive ankylosis by indomethacin. Inflammation Research. 34(1-2). 257–260. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Edgar M. Colin Breakdown of academic impact, for papers by A J Wysenbeek Breakdown of academic impact, for papers by Béatrice Bouvard Breakdown of academic impact, for papers by J Pourel Breakdown of academic impact, for papers by Maria Elena Secchi Breakdown of academic impact, for papers by B Zimmermann Breakdown of academic impact, for papers by A K Bhalla Breakdown of academic impact, for papers by R. W. Strachan Breakdown of academic impact, for papers by Folke D. Lindström Breakdown of academic impact, for papers by Daisuke Kobayashi
Rankless by CCL
2026